Autologous Hematopoietic Stem-Cell Transplantation for Relapsed or Refractory Hodgkin's Disease in Results of a study to determine the treatment outcome and clinical factors that are of prognostic significance for children and adolescents with relapsed or refractory Hodgkin's disease (HD) who received treatment with high-dose chemotherapy and autologous hematopoietic stem-cell transplantation (HSCT). www.jco.org/cgi/content/full/17/3/825reviews
High-Dose Therapy and Autologous Stem-Cell Transplantation for Adult Patients With Hodgkin's Diseas Report of a study with the purpose to investigate the results of high-dose therapy and autologous stem-cell transplantation (ASCT) in adults with Hodgkin's disease who do not enter remission after induction therapy, to determine overall survival (OS) and progression free survival (PFS), and to identify prognostic factors. www.jco.org/cgi/content/full/17/10/3101reviews
